Wojciech Mazur • Marilyn J. Siegel
Tomasz Miszalski-Jamka • Robert Pelberg

2013

Congenital heart disease (CHD) with a worldwide incidence of 0.8 % represents the most common class of inborn birth defects. Improvements in surgical techniques and medical management result in an increased life expectancy and lead to a greater number of children with CHD surviving into adulthood. It is now estimated that at least 85 % of children with CHD will survive to adulthood, and many of these patients will require follow-up medical care as an adult [1, 2].